News | Peripheral Artery Disease (PAD) | May 14, 2018

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

Online resource will provide patient-centered information on PAD risk factors, therapies and patient education

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and Treatment Resource Center. This center will be an ongoing, patient-centered quality improvement initiative focused on helping increase peripheral artery disease (PAD) awareness in the cardiovascular and internal medicine community by delving into the underlying risks of this disease state.

PAD impacts more than 10 million patients in the United States alone yet is woefully underdiagnosed. Lack of screening, underdiagnosis and undertreatment of PAD represent a critical gap in service to patients, as even asymptomatic PAD status is associated with the high long-term cardiovascular morbidity and mortality. Therefore, PAD has been targeted as one of SCAI’s key areas for quality improvement.

“I am excited to co-chair this important SCAI initiative on PAD awareness and education,” said Rajesh Swaminathan, M.D., FSCAI. “The condition is nearly as prevalent as CAD [coronary artery disease], yet still underdiagnosed. Early identification of PAD is key to proper counseling, risk factor modification and management to prevent future adverse clinical outcomes. The goal here is to provide PAD education, with incorporation of new clinical data in various formats, to inform and engage referring physicians, advanced practice providers, and fellows-in-training,” said Swaminathan.

The initiative also aims to improve the management and outcomes for PAD patients by providing a comprehensive review of “PAD 101.” This includes comprehensive discussions of:

  • Emerging data for secondary prevention in stable PAD;
  • Presentations to understand how to manage PAD patients; and
  • When to refer PAD patients for invasive therapies.

The multiyear program will be comprised of the following components:

  • The PAD Diagnosis and Treatment Resource Center: A five-part modular resource center hosted on SCAI’s website and packaged for easy download and dissemination; and
  • Webcast Series: A series of 30-minute webcasts based upon the PAD Diagnosis and Treatment Resource Center topics.

“The invasive therapy module will provide an evidence-based overview of the benefits of endovascular therapy and will help to clarify which patients should be considered for such therapy,” said Dmitriy Feldman, M.D., FSCAI, co-chair of the working group. “Furthermore, this module will focus on the SCAI-led Appropriate Use Criteria in EVT document as well as the newly released at SCAI 2018 Consensus Guidelines for Device Selection in Femoral-Popliteal Arterial Interventions.”

For more information: www.scai.org/padtoolkit

 

Related Content

Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Being Overweight May Change Young Adults' Heart Structure, Function
News | Cardiac Diagnostics | August 03, 2018
Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for...
High Intensity Exercise in Teenagers Could Ward Off Heart Disease

Ultrasound image of the carotid artery. Lines in yellow were used to determine arterial diameter and stretching before and following exercise.

News | Cardiac Diagnostics | July 16, 2018
New research published in Experimental Physiology has indicated potential differences in heart health benefits of...
News | Cardiac Diagnostics | June 14, 2018
A team of researchers says it has linked sensitivity to an allergen in red meat to the buildup of plaque in the...
The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.

The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.

 

Feature | Cardiac Diagnostics | May 07, 2018 | Steven D. Freedman, M.D., Ph.D.
 
Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
Overlay Init